IPO: the road to growth and opportunity
IPO: the road to growth and opportunity (Chinese)
ASX Life Science Investing and Funding Opportunities
A Guide to Listing in Australia DLA Piper
Dual Listing guide for New Zealand companies
Life Science code
ASX in conjunction with AusBiotech has recently updated The Code of Best Practice For Reporting by Life Science Companies. The Code is designed to bridge the "information gap" between the Life Science industry and investors by providing a disclosure framework that identifies the key drivers of value for Life Science companies and gives guidance to companies on the information investors need to make informed investment decisions. Ultimately it is designed to promote and support investor confidence in the sector.